New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF
LRND
6 hedge funds and large institutions have $380M invested in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
88% more capital invested
Capital invested by funds: $203M → $380M (+$177M)
37.27% more ownership
Funds ownership: 64.11% → 101.38% (+37%)
20% more funds holding
Funds holding: 5 → 6 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NYLIM
New York Life Investment Management
New York
|
+$136M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$501K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$13.7K |
| 4 |
SG
Sankala Group
Lyons,
Colorado
|
+$10.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GS
GTS Securities
Miami,
Florida
|
-$831K |
| 2 |
Goldman Sachs
New York
|
-$95.5K |
LRND Hedge Fund Activity: Q2 2026 in Review
6 of the 8,344 institutional investors tracked by Wall St. Rank reported a position in New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) for Q2 2026, worth a combined $380M — up 88% from $203M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new LRND positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was New York Life Investment Management, adding an estimated $136M. The largest seller was GTS Securities, exiting entirely with an estimated $831K sold.
- 6 institutional investors held New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF (LRND) as of Q2 2026, up from 5 in Q1 2026.
- Funds reported $380M of New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF stock for Q2 2026, up 88% quarter-over-quarter.
- 2 funds opened new New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF positions in Q2 2026 and 1 closed out, a net change of +1 holder.
- The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF buyer in Q2 2026 was New York Life Investment Management, an estimated $136M added.
- The largest New York Life Investments ETF Trust NYLIM U.S. Large Cap R&D Leaders ETF seller in Q2 2026 was GTS Securities, an estimated $831K sold.
Based on aggregated 13F filings for Q2 2026.